Fundraising Fox
Forty Seven Inc
acquired by GileadPalo Alto, US · Founded 2014 · 14,911 employees on LinkedIn · 7 known investors
Find your way into Forty Seven Inc
Sign up to see every warm intro you have to Forty Seven Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Forty Seven Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Gilead Sciences March 2020 · terms undisclosed
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries. The company combines scientific research with global partnerships to expand patient access to treatments.
Founders & leadership
Forty Seven Inc was founded in 2014 by Ravindra Majeti and Irving Weissman.
Board
Investors · 7
How we know: Bluebird Ventures's portfolio page · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lightspeed Venture Partners's portfolio page · board seat on SEC Form D · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$109.1M disclosed across 2 rounds · 2015–2017
▶$75MraisedOct 2017 · 32 investors · PharmaceuticalsRule 506(b)
- Ravindra MajetiDirector
- Mark A. McCamishExecutive Officer, Director
- Chris SchaepeDirector
- Irving WeissmanDirector
- Dennis HennerDirector
- Jeffrey BirdDirector
- Jonathan MacQuittyDirector
- Offering amount
- $75M
- Amount sold
- $75M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$34.1MraisedMar 2016 · 32 investors · PharmaceuticalsRule 506(b)
- Christopher SchaepeDirector
- Jeffrey BirdDirector
- Dennis HennerDirector
- Ravindra MajetiDirector
- Eric JensenExecutive Officer
- Irving WeissmanDirector
- Jonathan MacQuittyExecutive Officer, Director
- Offering amount
- $74.8M
- Amount sold
- $34.1M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Forty Seven Inc went on to found or lead other companies.
Frequently asked questions
- What does Forty Seven Inc do?
- Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries. The company combines scientific research with global partnerships to expand patient access to treatments.
- Who founded Forty Seven Inc?
- Forty Seven Inc was founded by Ravindra Majeti, Irving Weissman in 2014.
- Who are Forty Seven Inc's investors?
- Forty Seven Inc's investors include Bluebird Ventures, GV (Google Ventures), Lightspeed Venture Partners, Sofinnova Ventures, Clarus Ventures, Sutter Hill Ventures, Wellington Management.
- How much funding has Forty Seven Inc raised?
- Forty Seven Inc has disclosed $109.1M raised across 2 rounds.
- Who acquired Forty Seven Inc?
- Forty Seven Inc was acquired by Gilead.
- Where is Forty Seven Inc headquartered?
- Forty Seven Inc is headquartered in Palo Alto, US.